Robb Melissa, Hobbs Joanne K, Woodiga Shireen A, Shapiro-Ward Sarah, Suits Michael D L, McGregor Nicholas, Brumer Harry, Yesilkaya Hasan, King Samantha J, Boraston Alisdair B
Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Center for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
PLoS Pathog. 2017 Jan 5;13(1):e1006090. doi: 10.1371/journal.ppat.1006090. eCollection 2017 Jan.
The carbohydrate-rich coating of human tissues and cells provide a first point of contact for colonizing and invading bacteria. Commensurate with N-glycosylation being an abundant form of protein glycosylation that has critical functional roles in the host, some host-adapted bacteria possess the machinery to process N-linked glycans. The human pathogen Streptococcus pneumoniae depolymerizes complex N-glycans with enzymes that sequentially trim a complex N-glycan down to the Man3GlcNAc2 core prior to the release of the glycan from the protein by endo-β-N-acetylglucosaminidase (EndoD), which cleaves between the two GlcNAc residues. Here we examine the capacity of S. pneumoniae to process high-mannose N-glycans and transport the products. Through biochemical and structural analyses we demonstrate that S. pneumoniae also possesses an α-(1,2)-mannosidase (SpGH92). This enzyme has the ability to trim the terminal α-(1,2)-linked mannose residues of high-mannose N-glycans to generate Man5GlcNAc2. Through this activity SpGH92 is able to produce a substrate for EndoD, which is not active on high-mannose glycans with α-(1,2)-linked mannose residues. Binding studies and X-ray crystallography show that NgtS, the solute binding protein of an ABC transporter (ABCNG), is able to bind Man5GlcNAc, a product of EndoD activity, with high affinity. Finally, we evaluated the contribution of EndoD and ABCNG to growth of S. pneumoniae on a model N-glycosylated glycoprotein, and the contribution of these enzymes and SpGH92 to virulence in a mouse model. We found that both EndoD and ABCNG contribute to growth of S. pneumoniae, but that only SpGH92 and EndoD contribute to virulence. Therefore, N-glycan processing, but not transport of the released glycan, is required for full virulence in S. pneumoniae. To conclude, we synthesize our findings into a model of N-glycan processing by S. pneumoniae in which both complex and high-mannose N-glycans are targeted, and in which the two arms of this degradation pathway converge at ABCNG.
人类组织和细胞富含碳水化合物的外层为定殖和入侵细菌提供了首个接触点。鉴于N-糖基化是蛋白质糖基化的一种丰富形式,在宿主中具有关键的功能作用,一些适应宿主的细菌具备加工N-连接聚糖的机制。人类病原体肺炎链球菌利用酶将复杂的N-聚糖解聚,这些酶会在通过内切-β-N-乙酰氨基葡萄糖苷酶(EndoD,在两个GlcNAc残基之间切割)将聚糖从蛋白质上释放之前,依次将复杂的N-聚糖修剪成Man3GlcNAc2核心。在这里,我们研究了肺炎链球菌加工高甘露糖型N-聚糖并转运产物的能力。通过生化和结构分析,我们证明肺炎链球菌还拥有一种α-(1,2)-甘露糖苷酶(SpGH92)。这种酶能够修剪高甘露糖型N-聚糖的末端α-(1,2)-连接的甘露糖残基,生成Man5GlcNAc2。通过这种活性,SpGH92能够产生一种EndoD的底物,EndoD对带有α-(1,2)-连接甘露糖残基的高甘露糖型聚糖没有活性。结合研究和X射线晶体学表明,ABC转运蛋白(ABCNG)的溶质结合蛋白NgtS能够以高亲和力结合EndoD活性的产物Man5GlcNAc。最后,我们评估了EndoD和ABCNG对肺炎链球菌在模型N-糖基化糖蛋白上生长的贡献,以及这些酶和SpGH92对小鼠模型中致病性的贡献。我们发现EndoD和ABCNG都对肺炎链球菌的生长有贡献,但只有SpGH92和EndoD对致病性有贡献。因此,肺炎链球菌的完全致病性需要N-聚糖加工,但不需要释放的聚糖的转运。总之,我们将研究结果整合到肺炎链球菌加工N-聚糖的模型中,其中复杂型和高甘露糖型N-聚糖都是目标,并且该降解途径的两个分支在ABCNG处汇聚。